Michael Scolaro

Michael Scolaro

Dec 23, 2017

Group 6 Copy 864
3
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Community-based Leishmaniasis research in Sri Lanka

Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

Modeling Zika virus transmission from mother to child using uterine mini-organs

As of mid-2019, 87 countries have had or still have Zika cases, underlining the importance of this infectious...

The Down Low: Curbing the HIV Epidemic in Rural Louisiana

African American men who have sex with men (MSMs) are at higher risk for new HIV infections in rural communities...

Backer Badge Funded